Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress.
Hepatocyte growth factor (HGF) is known to promote renal epithelial cell survival by dual mechanisms involving Bad phosphorylation and Bcl-xL induction. However, it remains elusive as to the relative contributions of these two events to HGF-mediated cytoprotection. Here we investigated the role and mechanism of HGF in protecting renal epithelial cells from death induced by oxidant stress both in vitro and in vivo. Simultaneous incubation of human kidney proximal tubular epithelial cells (HKC-8) with HGF failed to protect them from oxidant stress-induced cell death, even though it was capable of inducing endogenous Akt and Bad phosphorylation. However, pre-incubation of HKC-8 cells with HGF for 48 hours dramatically promoted their survival and prevented caspase-3 cleavage and activation induced by H(2)O(2). A close association between Bcl-xL induction and effective cytoprotection by HGF was observed in HKC-8 cells after H(2)O(2) treatment. Furthermore, ectopic expression of exogenous Bcl-xL via adenoviral vector prevented H(2)O(2)-triggered caspase-3 activation. In a mouse model of acute kidney injury induced by ischemia/reperfusion, pre-administration of HGF expression vector drastically prevented apoptosis and largely preserved kidney function, whereas much less protective effect was observed when HGF gene was given immediately after ischemic injury. These results suggest that Bcl-xL induction plays an imperative role in mediating HGF cytoprotection of renal epithelial cells after death challenge.
Zhang
Jinglan
J
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Yang
Junwei
J
Liu
Youhua
Y
EMBO J. 1997 Feb 3;16(3):495-503
9034332
Pediatr Res. 2004 Sep;56(3):336-44
15201405
Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G639-46
17068118
J Biol Chem. 2003 Apr 4;278(14):12537-45
12560323
J Am Soc Nephrol. 2002 Oct;13(10):2464-77
12239235
Oncogene. 1998 Jul 16;17(2):131-41
9674697
Gene Ther. 2005 Nov;12(21):1551-8
15973441
Am J Pathol. 2005 Oct;167(4):947-57
16192631
Am J Physiol Renal Physiol. 2004 Jul;287(1):F7-16
15180923
J Am Soc Nephrol. 2002 Feb;13(2):411-422
11805170
Biochem Biophys Res Commun. 1998 May 29;246(3):821-6
9618296
Wound Repair Regen. 2006 Jan-Feb;14(1):2-10
16476066
Am J Physiol Renal Physiol. 2006 Jan;290(1):F35-42
16106037
Oncogene. 2000 Apr 27;19(18):2212-23
10822371
J Biol Chem. 2003 Jul 18;278(29):27080-7
12746445
EMBO J. 1996 Nov 15;15(22):6205-12
8947043
Curr Oncol Rep. 2007 Mar;9(2):102-8
17288874
J Biol Chem. 2002 Nov 1;277(44):42074-81
12200426
Science. 1997 Apr 4;276(5309):60-6
9082986
Am J Physiol. 1999 Oct;277(4):F624-33
10516287
J Lab Clin Med. 1997 Mar;129(3):318-29
9042817
Cell Signal. 2006 Nov;18(11):1967-76
16677802
Am J Pathol. 2001 Jan;158(1):275-80
11141501
Biochem Biophys Res Commun. 1998 Mar 27;244(3):683-90
9535725
Hepatology. 2007 May;45(5):1210-7
17464994
Kidney Int. 2001 Jun;59(6):2023-38
11380804
J Am Soc Nephrol. 2002 Jan;13(1):96-107
11752026
Nature. 1999 Sep 2;401(6748):86-90
10485711
Science. 1999 Nov 12;286(5443):1358-62
10558990
J Am Soc Nephrol. 2007 Aug;18(8):2340-9
17625116
Kidney Int. 2004 Apr;65(4):1231-9
15086462
Curr Opin Nephrol Hypertens. 2000 Jul;9(4):427-34
10926180
Curr Opin Neurobiol. 2001 Jun;11(3):297-305
11399427
Genes Dev. 1999 Nov 15;13(22):2905-27
10579998
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3485-92
15452053